---
case_studies:
- a4b2d790-f1ff-47bb-93b2-09b0d4619030
description: We guarantee your BDD application in 2 weeks. Unlock funding, accelerate
  FDA review, and signal market leadership.
featured: true
is_solution: true
service_name: Guaranteed Breakthrough Device Designation
sort_order: 10
title: Guaranteed Breakthrough Device Designation in 2 Weeks
widget_icon:
- /img/services/guaranteed-breakthrough-device-designation-5d7d68d6b3.svg
---

<div class="grid grid-cols-1 sm:grid-cols-2 gap-3">

<div class="[&_div.cta-wrapper]:my-4 [&_div.cta-wrapper]:sm:text-left [&_h1]:text-center [&_h1]:sm:text-left [&_h2]:text-center [&_h2]:sm:text-left [&_h2]:mt-0" markdown="1">

<div markdown="1">

# Unlock Funding and Market Confidence with Breakthrough Device Designation

</div>

<div markdown="1">

**Your board, investors, and market need signals of regulatory momentum.**

</div>

<div markdown="1">

Breakthrough Device Designation (BDD) from the FDA is the clearest signal you can send that:

</div>

<div markdown="1">

- Your device addresses an unmet medical need
- FDA has prioritized your review for expedited feedback and faster clearance
- You\'re positioned to raise capital and close strategic partnerships

</div>

<div markdown="1">

**The challenge:**

</div>

<div markdown="1">

- **You need it done yesterday** - Your next funding round, board meeting, or strategic partnership depends on showing regulatory momentum now
- **You need a full-service firm, not more tasks** - The last thing you need is a consultant handing you templates and adding to your team\'s workload. You need experts who own it end-to-end and deliver on autopilot

</div>

<div markdown="1">

**You need certainty and speed.**

</div>

<div markdown="1">

If we believe your device meets the criteria, we guarantee your Breakthrough Device Designation application will be granted.

</div>

<div markdown="1">

</div>

</div>

<div class="[&_div.cta-wrapper]:my-4 [&_div.cta-wrapper]:sm:text-left [&_h1]:text-center [&_h1]:sm:text-left [&_h2]:text-center [&_h2]:sm:text-left [&_h2]:mt-0" markdown="1">

<div markdown="1">

![](/img/services/Guaranteed_Breakthrough_Device_Designation-75f5b4a92ee64e5e8d388961902113a2.jpeg)

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

</div>

</div>

## Our Speed and Certainty Promise

**We guarantee your Breakthrough Device Designation application will be submitted to FDA in 4 weeks-or receive a partial refund.**

**We guarantee your Breakthrough Device Designation application will be approved by FDA or receive a partial refund.**

Unlike consultants who hand you templates, we own the entire process with our full-stack team of MDs, PhDs, regulatory experts, and engineers.

## Qualification Criteria

Not all devices qualify. You need:

1.  **A medical device that treats or diagnoses a life-threatening or irreversibly debilitating condition**
2.  **An argument that your device provides more effective and/or more equitable treatment or diagnosis compared to standard of care**
3.  **Early version of the device or algorithm** so we can articulate intended use and clinical benefit
4.  **Organizational priority** - BDD should be a top strategic objective

**Our selectivity protects you:** We only take on projects we believe have a strong likelihood of BDD approval. If we don't feel your device qualifies, we can help you get there!

<div class="not-prose text-center cta-wrapper"><a href="https://innolitics.com/contact/" class="bg-secondary text-white rounded hover:no-underline px-6 py-2 inline-block my-2 hover:transition-shadow hover:duration-150 hover:shadow hover:shadow-secondary/50 text-sm text-center">See if you Qualify!</a></div>

## Our Process: Battle-Tested. Guaranteed.

We\'ve successfully secured BDD for multiple clients. Our process:

### What You Get:

- **Eligibility assessment** against the eight BDD criteria
- **Complete BDD application package** including:
  - Device description and intended use
  - Demonstration of unmet medical need
  - Evidence of potential clinical benefit over standard of care
  - Preliminary development and testing plan
  - Supporting literature and clinical rationale
- **FDA eSTAR submission** prepared and filed
- **Strategic guidance** on leveraging BDD for fundraising and partnerships

**Timeline: Application submitted within 4 weeks of project start.**

<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0">Click for detailed BDD criteria and strategy</h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>The FDA grants Breakthrough Device Designation to devices that meet
<strong>all</strong> of the following criteria:</p>
<p><strong>Core Requirements:</strong></p>
<ol type="1">
<li>The device provides for <strong>more effective treatment or
diagnosis</strong> of life-threatening or irreversibly debilitating
diseases or conditions</li>
<li>The device meets at least one of the following:
<ul>
<li>Represents breakthrough technology</li>
<li>No approved or cleared alternatives exist</li>
<li>Offers significant advantages over existing alternatives</li>
<li>Device availability is in the best interest of patients</li>
</ul></li>
</ol>
<p><strong>Our Process:</strong></p>
<p><strong>Week 1: Discovery and Eligibility Assessment</strong></p>
<ul>
<li>Kick-off meeting with your team</li>
<li>Review device specifications, clinical data, and competitive
landscape</li>
<li>Assess eligibility against all eight BDD criteria</li>
<li>Identify gaps in available evidence or documentation</li>
<li>Deliverable: Eligibility assessment memo with go/no-go
recommendation</li>
</ul>
<p><strong>Week 2: Strategic Positioning and Device
Description</strong></p>
<ul>
<li>Identify strongest arguments for unmet medical need and clinical
benefit</li>
<li>Map comparable devices and articulate differentiation points</li>
<li>Draft comprehensive device description and intended use
statement</li>
<li>Develop breakthrough technology justification (if applicable)</li>
<li>Deliverable: Device description document and positioning
strategy</li>
</ul>
<p><strong>Week 3: Evidence Compilation and Application
Development</strong></p>
<ul>
<li>Compile supporting literature and clinical evidence</li>
<li>Document preliminary development and testing plan</li>
<li>Write comprehensive BDD request demonstrating:
<ul>
<li>Life-threatening or irreversibly debilitating condition</li>
<li>More effective treatment or diagnosis vs. standard of care</li>
<li>Breakthrough technology argument</li>
<li>Absence of alternatives or significant advantages</li>
</ul></li>
<li>Deliverable: Draft BDD application for client review</li>
</ul>
<p><strong>Week 4: Finalization and FDA Submission</strong></p>
<ul>
<li>Incorporate client feedback on draft application</li>
<li>Prepare FDA eSTAR package and all required attachments</li>
<li>Quality review and final approval</li>
<li>Submit to FDA</li>
<li>Deliverable: Complete FDA submission with confirmation receipt</li>
</ul>
<p><strong>Post-Submission:</strong></p>
<ul>
<li>FDA typically responds within 60 days with grant or denial</li>
<li>If granted: We help you leverage BDD for investor communications and
regulatory planning</li>
<li>If denied: We pivot to alternative regulatory strategies (covered
under our guarantee)</li>
</ul>
</div></details>

# Why Innolitics?

- **All we do is software as a medical device (SaMD) and AI as a medical device** since 2012
- **50+ SaMD and SiMD products** cleared through FDA
- **Multiple successful BDD applications** across imaging, diagnostics, and therapeutic devices
- **Full-time MDs, PhDs, software engineers, and regulatory experts** on staff
- We are the only ones offering a **speed and certainty guarantee**

<div class="grid grid-cols-1 sm:grid-cols-2 gap-3">

<div class="[&_div.cta-wrapper]:my-4 [&_div.cta-wrapper]:sm:text-left [&_h1]:text-center [&_h1]:sm:text-left [&_h2]:text-center [&_h2]:sm:text-left [&_h2]:mt-0" markdown="1">

<div markdown="1">

## **Case Studies**

</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

</div>

<div class="[&_div.cta-wrapper]:my-4 [&_div.cta-wrapper]:sm:text-left [&_h1]:text-center [&_h1]:sm:text-left [&_h2]:text-center [&_h2]:sm:text-left [&_h2]:mt-0" markdown="1">

<div markdown="1">

## Testimonials

</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">

</div>

</div>

</div>

# Our Publications

We are thought leaders in the AI/ML enabled medical device software space. Here are some of our [many articles and resources](https://innolitics.com/articles/):

<div class="grid grid-cols-1 sm:grid-cols-2 gap-3">

<div class="[&_div.cta-wrapper]:my-4 [&_div.cta-wrapper]:sm:text-left [&_h1]:text-center [&_h1]:sm:text-left [&_h2]:text-center [&_h2]:sm:text-left [&_h2]:mt-0" markdown="1">

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">

</div>

</div>

<div class="[&_div.cta-wrapper]:my-4 [&_div.cta-wrapper]:sm:text-left [&_h1]:text-center [&_h1]:sm:text-left [&_h2]:text-center [&_h2]:sm:text-left [&_h2]:mt-0" markdown="1">

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">



</div>

<div markdown="1">

</div>

<div markdown="1">

</div>

</div>

</div>

# FAQs

<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>How much does it cost?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>Pricing depends on your device and scope. <a
href="https://innolitics.com/contact/">Contact us</a> for a custom
quote.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>What is the FDA's timeline for BDD decisions?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>FDA typically responds within 60 calendar days of submission with a
grant or denial decision.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>Can I publicly announce my BDD?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>Yes. Many companies issue press releases upon BDD grant. It signals
FDA prioritization and regulatory momentum-both strong messages for
investors and strategic partners.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>Does BDD guarantee FDA clearance?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>No. BDD accelerates and prioritizes your review, but you still need
to meet FDA's safety and effectiveness standards. However, the
interactive review process significantly reduces regulatory risk.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>What happens if my BDD application is denied?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>If denied, you still have your standard regulatory pathway (510(k),
De Novo, or PMA). We'll pivot immediately to optimize that strategy. Our
guarantee covers this scenario.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>We already have a regulatory consultant. Can you still help?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>Absolutely. We frequently collaborate with in-house teams and
external consultants, particularly on AI/ML and software-specific
aspects of BDD applications.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>Can BDD help with non-US markets?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>BDD is US-specific, but it signals regulatory credibility globally.
We focus exclusively on FDA to maintain deep expertise, though we have
international partners for CE mark, Health Canada, etc.</p>
</div></details>
<details class="[&_svg.faq-plus-icon]:open:translate-y-[calc(100%+10px)] [&_svg.faq-plus-icon]:open:opacity-0 [&_svg.faq-minus-icon]:open:translate-y-0 [&_svg.faq-minus-icon]:open:opacity-100 bg-white my-4 py-4 px-3 sm:px-6 rounded border-solid border border-gray"><summary class="flex items-center list-none cursor-pointer [&::-webkit-details-marker]:hidden not-prose"><span class="relative text-center text-xl text-white font-medium mr-4 mt-0 w-[28px] h-[28px] shrink-0 flex justify-center items-center overflow-hidden rounded-full bg-secondary"><svg class="faq-plus-icon absolute transition block w-[12px] h-[12px] fill-inherit" viewBox="0 0 14 14"><path fill-rule="evenodd" clip-rule="evenodd" d="M7 0C7.55228 0 8 0.447715 8 1V6H13C13.5523 6 14 6.44772 14 7C14 7.55228 13.5523 8 13 8H8V13C8 13.5523 7.55228 14 7 14C6.44771 14 6 13.5523 6 13V8H1C0.447715 8 0 7.55228 0 7C0 6.44772 0.447715 6 1 6H6V1C6 0.447715 6.44772 0 7 0Z" fill="currentColor"></path></svg><svg xmlns="http://www.w3.org/2000/svg" class="faq-minus-icon absolute transition block w-[12px] h-auto fill-inherit translate-y-[calc(-100%-10px)] opacity-0" viewBox="0 0 24 24" stroke-width="4" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path d="M0 0h24v24H0z" stroke="none"/><path d="M5 12h14"/></svg></span><h3 class="text-heading m-0"><strong>What if I'm not sure we qualify?</strong></h3></summary><div class="mr-2 mt-6 [&_ul]:list-image-[url(/img/icons/ul-img.png)]"><p>Book a 30-minute assessment call. We'll evaluate your device against
BDD criteria and recommend the best path forward-whether BDD or an
alternative strategy.</p>
</div></details>

# Let\'s Talk

In a 30-minute call, we\'ll assess your device\'s BDD eligibility and provide a clear path to unlocking this strategic advantage.

<div class="not-prose text-center cta-wrapper"><a href="https://innolitics.com/contact/" class="bg-secondary text-white rounded hover:no-underline px-6 py-2 inline-block my-2 hover:transition-shadow hover:duration-150 hover:shadow hover:shadow-secondary/50 text-sm text-center">Schedule Your Assessment</a></div>
